Physician profile
Randy Hall
NPI 1992700587
$4,073.59
in general payments reported to CMS, 2019-2025
24 companies · $536 in 2025
The $536 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $118 · 2022: $579 · 2023: $1,605 · 2024: $1,236 · 2025: $536.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,377.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,376.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $637.96 | 2022-2025 | |
| Amgen INC. | $443.78 | 2022-2025 | Repatha, Repatha |
| Novo Nordisk INC | $394.86 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Pfizer INC. | $340.58 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $317.32 | 2022-2024 | Jardiance |
| Merck Sharp & Dohme LLC | $230.28 | 2022-2024 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $218.57 | 2021-2025 | Farxiga |
| Boston Scientific Corporation | $209.09 | 2022-2024 | Watchman Access System, Embold Fibered, Watchman |
| Janssen Pharmaceuticals, INC | $202.18 | 2022-2024 | Xarelto |
| Philips North America LLC | $193.08 | 2022-2025 | Extended Holter, Ecc Solutions, (Ck7) Extended Holter |
| E.R. Squibb & Sons, L.L.C. | $153.49 | 2022-2024 | Eliquis, Camzyos |
| Irhythm Technologies, INC. | $134.64 | 2023-2024 | Zio Xt Patch, Zio Monitor, Zio At Patch |
| Lexicon Pharmaceuticals, INC. | $94.50 | 2023-2024 | Inpefa |
| Medtronic, INC. | $89.25 | 2021-2025 | Micra |
| Sanofi-Aventis U.S. LLC | $82.31 | 2022-2023 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $71.30 | 2022-2024 | Lifevest |
| Baxter Healthcare | $53.02 | 2023-2024 | Hillrom - Cardiac Ambulatory Monitor |
| Abiomed | $43.50 | 2023-2025 | Impella |
| Edwards Lifesciences Corporation | $41.96 | 2022-2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Kiniksa Pharmaceuticals International, Plc | $36.48 | 2024 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $32.18 | 2024-2025 | |
| Axsome Therapeutics, INC. | $22.61 | 2023 | Auvelity |
| Atricure, INC. | $15.47 | 2023 | |
| Esperion Therapeutics, INC. | $15.18 | 2023 | Nexletol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randy Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.